Shares of Elevance Health Inc. ELV slipped 1.42% to $405.40 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.92% to 6,067.70 and the Dow Jones Industrial Average DJIA rising 0.31% to 44,850.35.

Elevance Health Inc. closed 27.50% below its 52-week high of $567.26, which the company achieved on September 3rd.

We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click here to read more.

S&P 500 notches closing record with focus on Trump comments, earnings January 24, 2025 Elevance Health on Thursday posted a better-than-feared fourth-quarter profit, which came as a relief to ...

Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for significant upside.

Elevance Health shares have added about 5.9% since the beginning of the year versus the S&P 500's gain of 3.5%. What's Next for Elevance Health? While Elevance Health has outperformed the market ...

U.S. stocks rose to a record as Wall Street regained some of the momentum that catapulted it to 57 all-time highs last year.

NEW YORK: The benchmark S&P 500 rose to a record closing high ... it forecast 2025 profit above estimates and shares in health insurer Elevance rose 2.7% after beating estimates for fourth-quarter ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Elevance Health delivered earnings and 2025 guidance that broadly met analysts’ expectations, likely providing some relief to investors after a challenging quarter. The fourth-quarter results ...

Elevance Health Inc.'s stock rose 2% Thursday ... The stock has fallen 16% in the last 12 months, while the S&P 500 SPX has gained 25%. Chip stocks and other AI-related plays take a hit as ...

Analysts' ratings for Elevance Health ELV over the last quarter vary from bullish to bearish, as provided by 6 analysts. Summarizing their recent assessments, the table below illustrates the ...